Side-by-side comparison of AI visibility scores, market position, and capabilities
Kingsport TN specialty chemicals (NYSE: EMN) at record $9.38B 2024 revenue, adjusted EPS $10.80 (+18%); Tritan copolyester (Nalgene/BPA-free), LLumar films, molecular recycling platform for CPG sustainability competing with Celanese.
Eastman Chemical Company is a Kingsport, Tennessee-based global specialty materials, chemicals, and fibers company — publicly traded on the New York Stock Exchange (NYSE: EMN) as an S&P 500 Materials component — producing advanced materials, chemical intermediates, and specialty fibers for transportation, building and construction, consumer products, and agricultural markets through approximately 14,000 employees in 9 manufacturing sites and 50+ countries. In fiscal year 2024, Eastman reported record revenue of $9.38 billion with earnings per share of $9.50 and adjusted EPS of $10.80 (+18% over 2023), with segment margins reaching a record 24.0% (+200 basis points over 2023) and approximately $1.3 billion in operating cash flow. The company returned $679 million to stockholders through dividends and share repurchases. CEO Mark Costa has led Eastman's strategic transformation since 2014 toward specialty chemicals with higher margins and proprietary market positions. Eastman's most strategically significant initiative is its molecular recycling platform — using methanolysis technology to recycle polyester and thermoplastic waste back to virgin-equivalent materials, with the Kingsport Tennessee "Polyester Renewal" facility (one of the world's largest molecular recycling plants) producing RSPO-certified recycled content for premium consumer brands including Estée Lauder, L'Oréal, and Procter & Gamble seeking recycled content for packaging commitments.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.